RxDoctor Payments Data

Paul Gardner

Neurological Surgery · Pittsburgh, PANPI 1407936271

Payments from drug & device makers

What this record shows

The money is spread across several categories — consulting fees (59.1%), travel and lodging and food and beverage — rather than concentrated in one kind of arrangement. 10 manufacturers reported payments, led by Stryker at 54.4% of the total. Reporting peaked in 2024 at $14,119 and has fallen 96.0% since, to $569 in 2025.

$27,202in general payments, 2019–2025

Across 58 payments — averaging $469.00 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Stryker$15K
  • Carl Zeiss Meditec, Inc.$5K
  • Medexus Pharma, Inc.$4K
  • Medtronic$2K
  • KARL Storz Endoscopy-america$887
  • Zimmer Biomet$246
  • plus $355 from 4 others
$152,130in research payments, 2019–2025

Across 23 payments — averaging $6614.33 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.

  • NX Development Corp.$107K
  • KARL Storz Endoscopy-america$45K

What the payments were for

  • Consulting fees$16,08059%
  • Speaking & faculty fees$3,00011%
  • Travel & lodging$5,09419%
  • Food & beverage$3,00811%
  • Education$200%

General payments by program year

19
20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$27,202 in reported general payments places this provider in the 80th percentile of 390 neurological surgery providers in Pennsylvania.

See all neurological surgery providers in Pennsylvania

Medicare billing

Part B allowed, 2024
$101,036
Medicare patients
124
Services billed
213

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
Acetazolamide ErAcetazolamide12$786
Prednisone14$11

Paid to pharmacies, not to this prescriber.

Other neurological surgery in Pittsburgh

See the full list for Pennsylvania

Where these figures come from

Is this you, or does something look wrong? →